Dept, of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
J Transl Med. 2011 Dec 16;9:216. doi: 10.1186/1479-5876-9-216.
Evading immune destruction and tumor promoting inflammation are important hallmarks in the development of cancer. Macrophages are present in most human tumors and are often associated with bad prognosis. Tumor associated macrophages come in many functional flavors ranging from what is known as classically activated macrophages (M1) associated with acute inflammation and T-cell immunity to immune suppressive macrophages (M2) associated with the promotion of tumor growth. The role of these functionally different myeloid cells is extensively studied in mice tumor models but dissimilarities in markers and receptors make the direct translation to human cancer difficult. This review focuses on recent reports discriminating the type of infiltrating macrophages in human tumors and the environmental cues present that steer their differentiation. Finally, immunotherapeutic approaches to interfere in this process are discussed.
逃避免疫破坏和促进肿瘤炎症是癌症发展的重要特征。巨噬细胞存在于大多数人类肿瘤中,通常与预后不良有关。肿瘤相关巨噬细胞有多种功能表型,包括众所周知的与急性炎症和 T 细胞免疫相关的经典激活巨噬细胞(M1),以及与肿瘤生长促进相关的免疫抑制巨噬细胞(M2)。这些功能不同的髓样细胞在小鼠肿瘤模型中得到了广泛研究,但标记物和受体的差异使得它们难以直接转化为人类癌症。本文综述了最近关于区分人类肿瘤浸润巨噬细胞类型以及指导其分化的环境线索的报道。最后,讨论了免疫治疗方法来干扰这一过程。